Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | 4.66% | 83.71 | 0.0% | $530.92m | |
| ICLR | ICON plc | -0.03% | 246.49 | 2.8% | $289.70m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -6.54% | 27.71 | 14.1% | $163.05m | |
| HZNP | Horizon Therapeutics Plc | -0.38% | 99.41 | 5.5% | $111.54m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.63% | 169.63 | 2.2% | $86.44m | |
| CTLT | Catalent, Inc. | 0.77% | 121.26 | 2.1% | $79.03m | |
| PRGO | Perrigo Co. Plc | -0.08% | 48.29 | 6.9% | $49.62m | |
| ENDP | Endo International Plc | -4.20% | 4.79 | 8.6% | $44.39m | |
| BHC | Bausch Health Cos., Inc. | -6.48% | 27.73 | 0.0% | $41.92m | |
| ARGX | argenx SE | 0.85% | 311.38 | 0.0% | $40.53m | |
| UTHR | United Therapeutics Corp. | -0.88% | 178.28 | 14.0% | $38.47m | |
| SAGE | SAGE Therapeutics, Inc. | -2.56% | 42.26 | 7.6% | $32.22m | |
| NTEC | Intec Parent, Inc. | -1.12% | 10.88 | 0.0% | $31.43m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | -3.26% | 12.84 | 9.6% | $24.21m | |
| AXSM | Axsome Therapeutics, Inc. | -0.95% | 49.84 | 1.9% | $17.95m |
Company Profile
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.